Skip to content

Study · Non-randomized trial · n = 96 · 1991

2 results

[The use of thymalin in the combined treatment of patients with disseminated cancer of the cervix uteri].

Vishnevskaia EE, Khavinson VKh, Nikolaeva DV

Voprosy onkologii1 Jan 1991

PMID2014686 (opens in a new tab)PepBankPUB-02014686
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In women with advanced cervical carcinoma, adding thymalin to radiotherapy allowed wider application of radical surgery than radiotherapy alone.

    In plain wordsIn women with advanced cervical cancer, adding thymalin to radiotherapy allowed wider use of radical surgery than radiotherapy alone.

    Peptide
    Thymalin
    Outcome
    IncreaseApplication of radical surgery
    Study

    n = 96

    Comparator
    Radiotherapy alone
    Outcome group
    Cancer treatment response · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results showed the latter therapeutic modality to offer clear advantage over radiotherapy alone, viz. it allowed wider application of radical surgery and assured better results of treatment of patients previously considered incurable.
    1 context sentence
    Summary · context
    Fifty-eight females of the control group received complex split-course radiotherapy whereas in 38 patients of the study group radiation was supplemented with thymalin immunotherapy at the first and second stages.
  2. 02HumanNon-randomized trialEfficacy outcome

    In women with advanced cervical carcinoma, adding thymalin to radiotherapy improved treatment results compared with radiotherapy alone.

    In plain wordsIn women with advanced cervical cancer, adding thymalin to radiotherapy improved treatment results compared with radiotherapy alone.

    Peptide
    Thymalin
    Outcome
    IncreaseTreatment results
    Study

    n = 96

    Comparator
    Radiotherapy alone
    Outcome group
    Cancer treatment response · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The results showed the latter therapeutic modality to offer clear advantage over radiotherapy alone, viz. it allowed wider application of radical surgery and assured better results of treatment of patients previously considered incurable.
    1 context sentence
    Summary · context
    Fifty-eight females of the control group received complex split-course radiotherapy whereas in 38 patients of the study group radiation was supplemented with thymalin immunotherapy at the first and second stages.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.